国际肿瘤肾脏病学会议要点:医学新兴领域
肿瘤肾脏病学是新兴领域,癌症患者可因肿瘤本身及治疗罹患肾脏病。近期国际会议汇集70名专家在8场全体会议(含5场主题演讲)中讨论该交叉领域关键问题,包括肾移植受者高肿瘤发生率等未解基础科学问题,48名青年学者通过2场大型壁报展示原创观察。
要点
- 肿瘤患者肾脏病源于肿瘤本身及抗癌治疗两方面。
- 肾内科医生需掌握肿瘤生物学与治疗以融入多学科团队。
- 肾移植受者高肿瘤发生率等基础科学问题尚待解决。
核心结论
- 肿瘤肾脏病学是医学新兴交叉领域,需肾内科医生掌握肿瘤生物学与治疗以优化管理癌症合并肾脏病患者。
研究设计与样本
- 国际会议汇集来自全球70名高水平专家,在8场全体会议(含5场主题演讲)中讨论肿瘤肾脏病学关键问题。
- 48名青年肾内科与肿瘤科医生受邀在2场大型壁报展示原创观察。
主要发现
- 会议讨论了肿瘤肾脏病学挑战性临床交叉界面的关键问题,包括肾移植受者高肿瘤发生率等未解基础科学问题。
临床怎么用
- 肾内科医生应了解肿瘤生物学与治疗,以充分融入多学科团队并优化管理癌症合并肾脏病患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Onco-nephrology is an emerging field in medicine. Patients with cancer may suffer from kidney diseases because of the cancer itself and cancer-related therapy. It is critical for nephrologists to be knowledgeable of cancer biology and therapy in order to be fully integrated in the multidisciplinary team and optimally manage patients with cancer and kidney diseases. In a recent international meeting, the key issues in this challenging clinical interface were addressed, including many unresolved basic science questions, such as the high tumor incidence in kidney transplant recipients. To this end, 70 highly qualified faculty members were gathered from all over the world to discuss these issues in 8 plenary sessions, including 5 keynote lectures. In addition, 48 young nephrologists and oncologists were invited to present their original observations that were highlighted in 2 large poster sessions.
引用
- Capasso A, Benigni A, Capitanio U, et al. Summary of the International Conference on Onco-Nephrology: an emerging field in medicine. Kidney Int. 2019. PMID: 31445584. doi:10.1016/j.kint.2019.04.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。